Mesenchymal Stem Cells Suppress Severe Asthma by Directly Regulating Th2 Cells and Type 2 Innate Lymphoid Cells

Patients with severe asthma have unmet clinical needs for effective and safe therapies. One possibility may be mesenchymal stem cell (MSC) therapy, which can improve asthma in murine models. However, it remains unclear how MSCs exert their beneficial effects in asthma. Here, we examined the effect o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jae Woo, Ryu, Seungwon, Ham, Jongho, Jung, Keehoon, Lee, Sangho, Chung, Doo Hyun, Kang, Hye-Ryun, Kim, Hye Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424137/
https://www.ncbi.nlm.nih.gov/pubmed/34462397
http://dx.doi.org/10.14348/molcells.2021.0101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424137/
https://www.ncbi.nlm.nih.gov/pubmed/34462397
http://dx.doi.org/10.14348/molcells.2021.0101

Ejemplares similares